GlassScriptPhysician profile
Jason Pozner
NPI 1285768457
$24,607.15
in general payments reported to CMS, 2019-2025
18 companies · $664 in 2025
The $664 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $68.21 · 2021: $524 · 2022: $561 · 2023: $901 · 2024: $4,253 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Food and Beverage: $2,818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Food and Beverage | $2,817.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $16,667.31 | 2019-2022 | |
| Galderma Laboratories, L.P. | $3,195.34 | 2019-2024 | |
| Davol INC. | $1,196.23 | 2022-2025 | Phasix Mesh, Arista Ah Flexitip |
| Endo Pharmaceuticals INC. | $959.76 | 2019 | |
| Abbvie INC. | $839.47 | 2023-2025 | |
| Merz North America, INC. | $398.42 | 2019-2025 | |
| Hill Dermaceuticals, INC. | $379.96 | 2024 | Tolak |
| Becton, Dickinson and Company | $271.88 | 2022-2025 | Phasix Mesh |
| Tepha INC | $149.47 | 2019 | |
| Apyx Medical Corporation | $137.68 | 2019-2020 | |
| Dilon Technologies, INC. | $131.46 | 2023 | Hemoblast Bellows |
| Revance Therapeutics, INC. | $114.27 | 2024 | Daxxify |
| Musculoskeletal Transplant Foundation INC. | $39.36 | 2025 | |
| Sientra, INC. | $31.98 | 2022 | |
| Almirall LLC | $28.61 | 2025 | Seysara |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aclaris Therapeutics, INC. | $22.50 | 2019 | |
| Mentor Worldwide LLC | $22.20 | 2022 | |
| Motiva USA, LLC | $21.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Pozner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.